Aurinia Pharmaceuticals Inc. (AUPH)
Biotechnology · Healthcare · $2.2B
Intrinsic Value (Consensus)
$46.68
Current Price
$16.48
Margin of Safety
+183.3%
183.3% Below Intrinsic Value
Value: $47
Price: $16
Valuation Model Estimates
Current Price: $16.48
DCF (Discounted Cash Flow)
$72.94
Graham Number
$14.72
Earnings Power Value
$17.42
Relative Value (P/E)
$49.69
Dividend Discount Model
Not applicable
—
Consensus Value
$46.68
Model Assumptions
Discount Rate
10.3%
Growth Rate
22.9%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
89
Profitability
25/25
Strength
17/25
Valuation
22/25
Growth
25/25
Financial Health Signals
Strong profitability — ROE of 49% (above 20% is excellent)
Strong earnings growth (23% YoY)
Key Financials
- EPS (TTM)
- $2.17
- EPS (Forward)
- $2.66
- Book Value
- $4.45
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 49.4%
- Debt/Equity
- —
- Revenue Growth
- 285.3%
- Earnings Growth
- 22.9%
- Dividend Yield
- N/A
- Beta
- 1.36
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance